SI
VIR icon

Sofinnova Investments’s Vir Biotechnology VIR Stock Holding History

Sofinnova Investments’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-83,010
Closed -$538K – 80
2025
Q1 		$538K Sell
83,010
-31,121
-27% -$277K 0.04% 62
2024
Q4 		$838K Sell
114,131
-15,115
-12% -$119K 0.06% 54
2024
Q3 		$968K Buy
+129,246
New +$1.12M 0.08% 55
2024
Q1 		– Sell
-4,495
Closed -$45.2K – 87
2023
Q4 		$45.2K Buy
+4,495
New +$41.1K ﹤0.01% 62
2023
Q3 		– Sell
-488,117
Closed -$12M – 75
2023
Q2 		$12M Sell
488,117
-169,442
-26% -$4.26M 0.78% 29
2023
Q1 		$15.3M Buy
+657,559
New +$16.8M 0.98% 27

Other funds holding VIR

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return